Neil Desai, EXECUTIVE CHAIRMAN at Aadi Bioscience, Inc. (AADI), sold 40,000 shares at $1.50 ($57K) on 2024-08-01, disclosed to the SEC on 2024-08-05.
Scheduled sale ($57k) by EXECUTIVE CHAIRMAN under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.50 | 15,415 | $23K | 40.3% |
| 2 | $1.41 | 18,933 | $27K | 46.5% |
| 3 | $1.34 | 5,652 | $8K | 13.2% |
| Total | $1.43 avg | 40,000 | $57K | 100% |
| Filing → |
| AADI | SELL | 2024-06-05 | $72K | — | Filing → |
| AADI | SELL | 2024-05-01 | $77K | — | Filing → |
| AADI | SELL | 2024-04-03 | $91K | — | Filing → |